Close

Analyst Ratings for Simcere Pharmaceutical Group. (SCR)

SCR Rating Summary

  |   Expand Research on SCR
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 4 / 10
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/17/2011 Morgan Stanley N/A Downgrade Equalweight
(N/A)
9.80
(N/A)
7.76
(7.50)
-3.35% Details
9/30/2011 Oppenheimer N/A Downgrade Perform
(N/A)
N/A
(N/A)
9.15
(7.50)
-18.03% Details